Abstracts

384 – Host Transcriptional Signatures Associated With Distinct Inflammatory Bioprofiles in People With HIV

Background Some people with HIV (PWH) exhibit high levels of inflammation despite effective treatment. In two independent cohorts of treated PWH, we previously demonstrated that PWH fall into three distinct inflammatory clusters: cluster 1 defined by lower inflammation, cluster 2 by high innate immune activation, gut microbial translocation, vascular inflammation, and cluster 3 by gut…

380 – Extracellular Vesicles From the Cells Harboring HIV Defective Provirus Initiate Inflammatory Cascade

Background It has been demonstrated that over 95% of provirus present in the peripheral blood of people living with HIV on combination antiretroviral therapy are defective. Defective viruses have long been considered biologically irrelevant, as they cannot encode infectious viruses. However, recent studies have shown that these defective viruses are translationally active, raising potential concerns…

363 – Prevalence and Activity of Anti-Interferon Autoantibodies in People Living With HIV

Background The interferon (IFN) cytokine family, encompassing subtypes 1-3, is fundamental to control of HIV replication. Anti-IFN auto-antibodies (auto-Abs) have emerged as key determinants of severe acute viral infection but data are limited in chronic virus infections. A single cohort study of people living with HIV (PLWH) has reported anti-Type 1 IFN (T1IFN) auto-Ab prevalence…

389 – Methamphetamine Use Disorder in ART PWH Is Associated With Elevated NLRP3 Inflammasome Activation

Background Despite effective antiretroviral therapy (ART), people with HIV (PWH) experience higher morbidity and mortality rates than people without HIV due to ongoing inflammation from persistent HIV. Methamphetamine (MA) use disorder among PWH is linked to lower ART adherence, increased viral resistance and poorer clinical outcomes. We recently demonstrated that MA exposure during ART is…

349 – Transcriptionally Active Defective HIV-1 Proviruses Persist in All CD4 T-Cell Subsets During ART

Background More than 95% of HIV-1 proviruses detected are defective but often associated with RNA transcripts during antiretroviral therapy (ART). These transcriptionally active defective proviruses may contribute to persistent immune activation seen in people with HIV (PWH) receiving ART. The distribution and persistence of these transcriptionally active defective proviruses has not been described. Methods 11…

360 – Variability in Immunometabolic Signatures Among People w/ HIV Defines Immune Outcomes and Progression

Background HIV infection leads to significant loss of CD4 T lymphocytes (CD4TL), compromising immune function despite antiretroviral therapy (ART). People living with HIV (PLHIV) can be categorized as immune responders (IR) or immune non-responders (INR) based on their ability to achieve immune reconstitution. IR restore CD4TL counts >500 cells/mm³, while INR remain below this threshold…